- Home
- PRTG vs PRSO Comparison
PRTG vs PRSO Comparison
Compare PRTG & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTG
- PRSO
- Stock Information
- Founded
- PRTG 1973
- PRSO 2008
- Country
- PRTG British Virgin Islands
- PRSO United States
- Employees
- PRTG N/A
- PRSO N/A
- Industry
- PRTG Oil & Gas Production
- PRSO Semiconductors
- Sector
- PRTG Energy
- PRSO Technology
- Exchange
- PRTG Nasdaq
- PRSO Nasdaq
- Market Cap
- PRTG 4.7M
- PRSO 4.2M
- IPO Year
- PRTG N/A
- PRSO 2001
- Fundamental
- Price
- PRTG $4.69
- PRSO $0.85
- Analyst Decision
- PRTG Hold
- PRSO Strong Buy
- Analyst Count
- PRTG 1
- PRSO 2
- Target Price
- PRTG N/A
- PRSO $3.38
- AVG Volume (30 Days)
- PRTG 40.3K
- PRSO 333.9K
- Earning Date
- PRTG 12-03-2024
- PRSO 11-12-2024
- Dividend Yield
- PRTG N/A
- PRSO N/A
- EPS Growth
- PRTG N/A
- PRSO N/A
- EPS
- PRTG N/A
- PRSO N/A
- Revenue
- PRTG N/A
- PRSO $12,727,000.00
- Revenue This Year
- PRTG N/A
- PRSO $17.49
- Revenue Next Year
- PRTG N/A
- PRSO $0.67
- P/E Ratio
- PRTG N/A
- PRSO N/A
- Revenue Growth
- PRTG N/A
- PRSO N/A
- 52 Week Low
- PRTG $2.10
- PRSO $0.73
- 52 Week High
- PRTG $40.80
- PRSO $11.20
- Technical
- Relative Strength Index (RSI)
- PRTG 46.17
- PRSO 33.52
- Support Level
- PRTG $3.81
- PRSO $0.75
- Resistance Level
- PRTG $4.78
- PRSO $0.89
- Average True Range (ATR)
- PRTG 0.56
- PRSO 0.16
- MACD
- PRTG 0.04
- PRSO -0.03
- Stochastic Oscillator
- PRTG 56.33
- PRSO 13.95
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.